Drug Approval | March 22, 2023
Zydus granted Orphan Drug Designation by USFDA for ZYIL1
ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
All children (100%) in the presymptomatic intravenous cohort of LT-002 maintained or achieved all assessed motor milestones, including independent walking
Various healthcare companies are already implementing high-tech solutions into existing healthcare systems.
The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
The observations are procedural in nature
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective
The collaboration between both the ministries will play an important role in enhancing the skill and service sector related to Ayurveda
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
Subscribe To Our Newsletter & Stay Updated
